{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:08:38Z","timestamp":1759777718163},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T00:00:00Z","timestamp":1357603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/nrneurol.2012.274","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T14:46:21Z","timestamp":1357656381000},"page":"68-70","source":"Crossref","is-referenced-by-count":17,"title":["Major advances in the treatment of stroke"],"prefix":"10.1038","volume":"9","author":[{"given":"Miguel","family":"Blanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,8]]},"reference":[{"key":"BFnrneurol2012274_CR1","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","volume":"379","author":"P Sandercock","year":"2012","unstructured":"Sandercock, P.  et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379, 2352\u20132363 (2012).","journal-title":"Lancet"},{"key":"BFnrneurol2012274_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0140-6736(12)60813-7","volume":"380","author":"A D\u00e1valos","year":"2012","unstructured":"D\u00e1valos, A.  et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 380, 349\u2013357 (2012).","journal-title":"Lancet"},{"key":"BFnrneurol2012274_CR3","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/01.STR.0000038691.03334.71","volume":"33","author":"A D\u00e1valos","year":"2002","unstructured":"D\u00e1valos, A.  et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 33, 2850\u20132857 (2002).","journal-title":"Stroke"},{"key":"BFnrneurol2012274_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey, J. S.  et al. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366, 120\u2013129 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2012274_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf, P. A., Abbott, R. D. & Kannel, W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22, 983\u2013988 (1991).","journal-title":"Stroke"},{"key":"BFnrneurol2012274_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/hs0302.104543","volume":"33","author":"C Lamy","year":"2002","unstructured":"Lamy, C.  et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Stroke 33, 706\u2013711 (2002).","journal-title":"Stroke"},{"key":"BFnrneurol2012274_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan, A. J.  et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N. Engl. J. Med. 366, 991\u2013999 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2012274_CR8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"BFnrneurol2012274_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/stem.1104","volume":"30","author":"K Oki","year":"2012","unstructured":"Oki, K.  et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 30, 1120\u20131133 (2012).","journal-title":"Stem Cells"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.274","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:09:29Z","timestamp":1684469369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2012.274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,8]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFnrneurol2012274"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2012.274","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,8]]}}}